ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. FASTRACK II: Expanding the Role of SABR…

FASTRACK II: Expanding the Role of SABR in Localized Renal Cell Carcinoma

European Urology·August 5
Urology & Nephrology

Related Questions

Explore related topics

What is the evidence for SABR in localized renal cell carcinoma?How does stereotactic ablative radiotherapy compare to surgery or ablation for early-stage kidney cancer?What are the outcomes of FASTRACK trials for renal cell carcinoma?

Publication Details

Year
2026
Journal
European Urology
Source
View article
Keep scrolling
More content below.
Up Next